Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genpact (G) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Genpact (G) over the last 17 years, with Q3 2025 value amounting to $740.8 million.

  • Genpact's Cash & Equivalents fell 2756.42% to $740.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $740.8 million, marking a year-over-year decrease of 2756.42%. This contributed to the annual value of $648.2 million for FY2024, which is 1106.38% up from last year.
  • Genpact's Cash & Equivalents amounted to $740.8 million in Q3 2025, which was down 2756.42% from $663.3 million recorded in Q2 2025.
  • Over the past 5 years, Genpact's Cash & Equivalents peaked at $1.0 billion during Q3 2024, and registered a low of $460.4 million during Q2 2022.
  • Over the past 5 years, Genpact's median Cash & Equivalents value was $646.8 million (recorded in 2022), while the average stood at $679.1 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first plummeted by 4377.3% in 2022, then surged by 8902.76% in 2024.
  • Genpact's Cash & Equivalents (Quarter) stood at $899.5 million in 2021, then dropped by 28.09% to $646.8 million in 2022, then dropped by 9.76% to $583.7 million in 2023, then rose by 11.06% to $648.2 million in 2024, then rose by 14.27% to $740.8 million in 2025.
  • Its Cash & Equivalents was $740.8 million in Q3 2025, compared to $663.3 million in Q2 2025 and $561.6 million in Q1 2025.